Approval · Notice of Compliance 36635 · 2025
DRAXIMAGE MAA: Notice of Compliance 36635
Issued December 22, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36635
- Date
- December 22, 2025
- Company
- Jubilant Draximage Inc.Kirkland, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to Labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRAXIMAGE MAA | Not yet assigned | — |
Medicinal ingredients
- ALBUMIN 2.5 MG per VIAL